Get started
Cabaletta Bio, Inc.Cabaletta Bio, Inc.Cabaletta Bio, Inc.

Cabaletta Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

CABA chart


Full chart

CABA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪59.12 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.34 USD
Net income (FY)
‪−115.86 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪46.16 M‬
Beta (1Y)
3.57

Employees


Employees (FY)
161
Change (1Y)
+58 +56.31%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−719.65 K‬ USD

About Cabaletta Bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Steven Nichtberger
Website
cabalettabio.com
Headquarters
Philadelphia
Founded
2017
FIGI
BBG00MJ3BKW2
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CABA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CABA.

Frequently Asked Questions


The current price of CABA is 1.17 USD — it has decreased by −5.28% in the past 24 hours. Watch Cabaletta Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cabaletta Bio, Inc. stocks are traded under the ticker CABA.
CABA stock has risen by 7.87% compared to the previous week, the month change is a −35.99% fall, over the last year Cabaletta Bio, Inc. has showed a −93.16% decrease.
We've gathered analysts' opinions on Cabaletta Bio, Inc. future price: according to them, CABA price has a max estimate of 28.00 USD and a min estimate of 3.00 USD. Watch CABA chart and read a more detailed Cabaletta Bio, Inc. stock forecast: see what analysts think of Cabaletta Bio, Inc. and suggest that you do with its stocks.
CABA reached its all-time high on Feb 8, 2024 with the price of 26.35 USD, and its all-time low was 0.59 USD and was reached on Sep 23, 2022. View more price dynamics on CABA chart.
See other stocks reaching their highest and lowest prices.
CABA stock is 0.43% volatile and has beta coefficient of 3.57. Track Cabaletta Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cabaletta Bio, Inc. there?
Today Cabaletta Bio, Inc. has the market capitalization of ‪59.12 M‬, it has decreased by −2.14% over the last week.
Yes, you can track Cabaletta Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Cabaletta Bio, Inc. is going to release the next earnings report on May 14, 2025. Keep track of upcoming events with our Earnings Calendar.
CABA earnings for the last quarter are −0.65 USD per share, whereas the estimation was −0.64 USD resulting in a −1.71% surprise. The estimated earnings for the next quarter are −0.65 USD per share. See more details about Cabaletta Bio, Inc. earnings.
Cabaletta Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CABA net income for the last quarter is ‪−32.59 M‬ USD, while the quarter before that showed ‪−30.63 M‬ USD of net income which accounts for −6.39% change. Track more Cabaletta Bio, Inc. financial stats to get the full picture.
No, CABA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 161 employees. See our rating of the largest employees — is Cabaletta Bio, Inc. on this list?
Like other stocks, CABA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cabaletta Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cabaletta Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cabaletta Bio, Inc. stock shows the sell signal. See more of Cabaletta Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.